jama glp-1 Internal Medicine on X: "@SocietyGIM Antiobesity medications may improve weight loss and health outcomes by altering biological processes related to appetite. ➡️ This Review summarizes the efficacy and safety of #AOMs There's an interesting study out

By overcoming current limitations, biologics could usher in a new era of cardiovascular care, offering safer, more effective, and personalized treatment options for patients worldwide

The best way to administer this antioxidant is intravenously or intramuscularly

Too much of it can leave you jittery, anxious and unable to catch good ZZZs at night

R.BrierleyD

In monotremes the changes observed indicate that there is selective conflict between GLP-1s function in venom and its traditional function

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 trial